Physician profile
Peter Carl Devito
NPI 1871513150
$2,373.02
in general payments reported to CMS, 2019-2025
10 companies · $279 in 2025
The $279 reported for 2025 was less than what a typical Plastic Surgery provider received nationally (typical 2025 total: $380).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $287 · 2020: $86.56 · 2021: $166 · 2022: $204 · 2023: $540 · 2024: $811 · 2025: $279.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $1,629.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $1,629.21 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Mentor Worldwide LLC | $600.84 | 2019-2025 | Mentor Memorygel Resterilizable Gel Sizer, Artoura Breast Tissue Expander |
| Tela Bio, INC. | $343.63 | 2024-2025 | Ovitex Reinforced Bioscaffold With Permanent Polymer (Ovitex), Ovitex 2s |
| Kci USA, INC. | $277.65 | 2019-2023 | V.A.C. Veraflo, Prevena, V.A.C. Dermatac |
| Integra Lifesciences Corporation | $272.52 | 2022-2024 | Integra, Integra Dermal Regeneration Template, Omnigraft |
| Smith+Nephew, INC. | $253.25 | 2023-2024 | Grafix Pl, Stravix |
| Sientra, INC. | $165.86 | 2021 | |
| Kerecis Limited | $121.33 | 2024 | Kerecis Omega3 Marigen, Kerecis Omega3 Surgiclose |
| Axogen | $116.47 | 2023-2024 | Avance Nerve Graft, Axoguard Ha+ Nerve Protector, Axoguard Nerve Protector |
| Depuy Synthes Sales INC. | $115.73 | 2024 | Trumatch |
| Acera Surgical, INC. | $105.74 | 2023 | Restrata Wound Matrix |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Peter Devito listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.